These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6791738)

  • 1. Plasma exchange in non-haemophiliac patients with inhibitors to factor VIIIC.
    Erskine JG; Burnett AK; Walker ID; Davidson JF
    Br Med J (Clin Res Ed); 1981 Sep; 283(6294):760. PubMed ID: 6791738
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of patients with factor VIII autoantibodies by staphylococcal protein A-based immunoadsorption and immunosuppression.
    Mansouri Taleghani B; Grossmann R
    Br J Haematol; 2001 Sep; 114(4):956-8. PubMed ID: 11564094
    [No Abstract]   [Full Text] [Related]  

  • 3. An idiopathic factor VIII anticoagulant: resolution following plasmapheresis and cytotoxic therapy.
    Goldsmith JC; Hamilton HE
    Am J Med Sci; 1985 Dec; 290(6):246-8. PubMed ID: 3936359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of life-threatening bleeding by combined plasmapheresis and immunosuppressive treatment in a haemophiliac with inhibitors.
    Révész T; Mátyus J; Goldschmidt B; Harsanyi V
    Arch Dis Child; 1980 Aug; 55(8):641-3. PubMed ID: 6776907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmapheresis: its value in the management of patients with antibodies to factor VIII.
    Francesconi M; Korninger C; Thaler E; Niessner H; Höcker P; Lechner K
    Haemostasis; 1982; 11(2):79-86. PubMed ID: 6806156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibitors (antibodies) directed against factor VIII in hemophilia A (author's transl)].
    Beck EA
    Ther Umsch; 1979 Apr; 36(4):326-9. PubMed ID: 377556
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antifactor VIII antibody in Rosai-Dorfman disease].
    Lorenzini JL; Allain JP; Chalopin JM; Rifle G; Devilliers E; Carli PM; Cortet P; Bonhomme J
    Nouv Rev Fr Hematol (1978); 1983; 25(1):23-6. PubMed ID: 6403924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Successful treatment of acquired F:VIII C inhibitor after delivery using plasmapheresis and high doses of immunoglobulins].
    Belić A; Pejin D; Canak V; Felle D; Lucić A
    Med Pregl; 1994; 47(9-10):359-61. PubMed ID: 7565328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amidolytic end-point methods for factor VIIIC inhibitors.
    Mackie IJ; Seghatchian MJ
    Med Lab Sci; 1982 Oct; 39(4):345-50. PubMed ID: 6817016
    [No Abstract]   [Full Text] [Related]  

  • 10. Serial plasmapheresis in a haemophiliac with antibodies to FVIII.
    Cobcroft R; Tamagnini G; Dormandy KM
    J Clin Pathol; 1977 Aug; 30(8):763-5. PubMed ID: 599190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simple procedure for accurate quantitation of factor VIII inhibitors.
    Tse D; Fekete L; Shanbrom E
    Thromb Diath Haemorrh; 1970 Feb; 23(1):19-25. PubMed ID: 5420431
    [No Abstract]   [Full Text] [Related]  

  • 12. Current treatment of patients with inhibitors to factor VIII.
    Hilgartner MW
    Haematologia (Budap); 1986; 19(1):21-32. PubMed ID: 3087840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful management of a patient with an acquired factor VIII inhibitor.
    Sultan Y; Maisonneuve P; Bismuth A; Steg A
    Transfusion; 1983; 23(1):62-4. PubMed ID: 6402833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmapheresis and Factor VIIIC inhibitors.
    Hambley H; Watkins R; Tansey PA; Walker ID; Davidson JF
    Lancet; 1985 Feb; 1(8423):274. PubMed ID: 2857337
    [No Abstract]   [Full Text] [Related]  

  • 15. [Acquired hemophilia A due to factor VIIIC inhibitor: detection of circulating immune complexes containing factor VIIIC but not factor VIIIR].
    Pfyffer M; Kistler HJ; von Felten A
    Schweiz Med Wochenschr; 1983 Oct; 113(40):1456-9. PubMed ID: 6417777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma exchange for coagulopathy and/or coagulation inhibitors.
    Spero JA
    J Clin Apher; 1985; 2(4):278-81. PubMed ID: 3934146
    [No Abstract]   [Full Text] [Related]  

  • 17. [Successful treatment of massive hemorrhagic diathesis caused by Factor VIII:C-antibodies with adsorption plasmapheresis and immunosuppression].
    Mondorf W; Grützmacher P; Schmidt H; Wolff B; Scharrer I; von Baum H
    Med Klin (Munich); 1991 Mar; 86(3):165-70, 171. PubMed ID: 1903498
    [No Abstract]   [Full Text] [Related]  

  • 18. The treatment of patients having spontaneously occurring antibodies to antihaemophilic factor (factor VIII).
    Rizza CR; Edgcumbe JO; Pitney WR; Child JA
    Thromb Diath Haemorrh; 1972 Aug; 28(1):120-8. PubMed ID: 5074988
    [No Abstract]   [Full Text] [Related]  

  • 19. [Plasma and plasma fractions in the therapy of blood coagulation disorders].
    Lechler E
    Internist (Berl); 1974 Sep; 15(9):461-4. PubMed ID: 4609113
    [No Abstract]   [Full Text] [Related]  

  • 20. Successful operation on a haemophiliac with Factor VIII inhibitor treated by plasmapheresis and Factor VIII infusions.
    Monteagudo J; Puig LL; Lao J; Labal F; Pina F; Maragall S; Gelabert A; Castillo R
    Transfusion; 1985; 25(1):85-6. PubMed ID: 3918365
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.